Determinants of all-cause mortality among HIV-positive patients started on antiretroviral therapy (n=1444)
| Age and sex adjusted | Multivariable adjusted | |||
|---|---|---|---|---|
| Variable | HR (95% CI) | p Value | HR (95% CI) | p Value |
| Age, per year | 1.01 (0.98 to 1.03) | 0.56 | 1.01 (0.99 to 1.03) | 0.37 |
| Male sex | 1.44 (0.94 to 2.11) | 0.10 | 2.15 (1.34 to 3.45) | 0.002 |
| Rural residency | 1.14 (0.62 to 2.09) | 0.68 | – | |
| Active tuberculosis | 1.59 (0.97 to 2.61) | 0.07 | 2.35 (1.40 to 3.92) | 0.002 |
| WHO stages III–IV | 4.57 (1.68 to 12.47) | 0.004 | 3.63 (1.29 to 10.24) | 0.02 |
| Weight, per kg lower | 1.04 (1.02 to 1.06) | 0.0002 | 1.03 (1.01 to 1.05) | 0.01 |
| Platelet count, per 1000 lower | 1.01 (0.99 to 1.03) | 0.53 | – | |
| CD4 count, per 10/mm3 lower | 1.06 (1.02 to 1.09) | 0.003 | 1.04 (1.01 to 1.07) | 0.02 |
| Haemoglobin, per g/dL lower | 1.14 (1.03 to 1.26) | 0.02 | 1.12 (1.00 to 1.26) | 0.05 |
| AZT-based regimens | 0.91 (0.51 to 1.62) | 0.76 | – | |
AZT, zidovudine.